Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Allograft rejection | R-HSA-9679028 | map05330 | lactobionic acid | 7314 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | lactobionic acid | 7314 | drug-path |
| Glioma | Q9NZM4 | map05214 | flupentixol | 5281881 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | flupentixol | 5281881 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | flupentixol | 5281881 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | flupentixol | 5281881 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | flupentixol | 5281881 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | flupentixol | 5281881 | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | flupentixol | 5281881 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | flupentixol | 5281881 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | cefixime | 175540 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | cefixime | 175540 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | cefixime | 175540 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | cefixime | 175540 | drug-path |
| Asthma | R-HSA-444620 | map05310 | cefixime | 175540 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | cefixime | 175540 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | cefixime | 175540 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | cefixime | 175540 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | cefixime | 175540 | drug-path |
| Axon guidance | R-HSA-422475 | map04360 | cefixime | 175540 | drug-path |